Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,591.50
Bid: 1,591.50
Ask: 1,592.00
Change: -13.00 (-0.81%)
Spread: 0.50 (0.031%)
Open: 1,613.00
High: 1,613.00
Low: 1,591.00
Prev. Close: 1,604.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON BRIEFING: Unilever CEO to step down; RPS backs new takeover bid

Mon, 26th Sep 2022 07:47

(Alliance News) - All eyes will be on the pound when traders in Europe return to desks on Monday, after the UK currency fell to an all-time low during the Asian session.

Sterling fell to an intraday low of USD1.0349 earlier Monday, its worst ever level against the dollar, bucking a wider downward trend for global equities.

The weaker pound means the FTSE 100 index of big international companies was called to open higher on Monday.

Sterling has struggled since UK Chancellor Kwasi Kwarteng announced a series of tax cuts and spending plans in a 'fiscal event' on Friday. The mini-budget caused "mega upset", analysts at Liberum commented.

"With income tax cuts, stamp duty reductions, scrapped corporate tax increases and bankers' bonus caps, investors are worried about the government's ability to finance these initiatives without incurring massive debt as the cost of borrowing is continuing to increase," the investment bank explained.

The UK chancellor hinted more tax cuts would follow those he announced last week.

Kwarteng, who has launched a review of all tax rates ahead of a formal budget, is reportedly considering abolishing a charge for parents who earn more than GBP50,000 and claim child benefit, increasing the annual allowances on pension pots, and a tax break for people who stay at home to care for children or loved ones.

On the UK corporate front, there were a series of M&A and director moves to distract attention from the pound and politics.

Here is what you need to know ahead of the London market open:

----------

MARKETS

----------

FTSE 100: called up 0.5% at 7,055.60

----------

Hang Seng: down 1.0 % at 17,749.72

Nikkei 225: down 2.7% at 26,431.55

S&P/ASX 200: down 1.6% at 6,469.40

----------

DJIA: closed down 486.27 points, 1.6%, at 29,590.41

S&P 500: closed down 64.76 points, 1.7%, at 3,693.23

Nasdaq Composite: closed down 198.88 points, 1.8%, at 10,867.93

----------

EUR: down at USD0.9646 (USD0.9691)

GBP: down at USD1.0608 (USD1.0869)

USD: up at JPY143.92 (JPY143.28)

GOLD: down at USD1,637.66 per ounce (USD1,643.77)

OIL (Brent): up at USD84.56 a barrel (USD86.34)

(changes since previous London equities close)

----------

ECONOMICS

----------

Monday's key economic events still to come:

09:00 BST Germany IFO business climate index

14:45 BST US Fed Boston President Susan Collins speaks

17:00 BST US Fed Atlanta President Raphael Bostic live event

21:00 BST US Fed Cleveland President Loretta Mester speaks

----------

The average UK house price tag increased by 0.7% month-on-month in September, according to property website Rightmove. Across Britain, the average asking price of a property coming to market is GBP367,760. Rightmove said the price increase is in line with the average September rise of 0.6% over the last 10 years. Prices had fallen 1.3% in August from July. Rightmove added that price growth this month is being driven predominantly by the middle and high-end market sectors. On an annual basis, growth quickened to 8.7% in September from 8.2% in August.

----------

Ireland's ambassador to the UK has stressed the need to find a negotiated solution to the problems surrounding Northern Ireland's post-Brexit arrangements. Martin Fraser said he was an optimist about the chances of resolving the issues around the Northern Ireland protocol but the situation was currently in the "words phase" and had to move to the "actions phase". The UK government is legislating to effectively tear up parts of the agreement, which sets out how goods flowing from Great Britain to Northern Ireland are treated. Fraser, speaking at a fringe event at the Labour Party conference in Liverpool, said the protocol was the only way to resolve the problems caused by Brexit.

----------

Ukrainian President Volodymyr Zelensky says he takes Russia's nuclear threats seriously and does not believe Russian President Vladimir Putin is bluffing. "Maybe yesterday it was a bluff. Now, it could be a reality," Zelensky told US broadcaster CBS News in a Sunday interview. "He wants to scare the whole world. These are the first steps of his nuclear blackmail. I don't think he's bluffing," Zelensky said, pointing to Russian shelling at Ukraine's Zaporizhzhya nuclear power plant.

----------

BROKER RATING CHANGES

----------

Berenberg raises Unilever to 'buy' ('hold') - price target 4,800 (4,000) pence

----------

JPMorgan cuts BP to 'neutral' ('overweight') - price target 520 (530) pence

----------

Berenberg raises Close Brothers to 'buy' ('hold') - price target 1,250 (1,100) pence

----------

Bernstein raises Aston Martin to 'outperform' (market-perform) - price target 180 (460) pence

----------

RBC resume Hunting with 'outperform' - 400 pence price target

----------

COMPANIES - FTSE 100

----------

Unilever said Chief Executive Alan Jope will step down at the end of next year, after five years in the post. The consumer goods company will kick off a formal search for Jope's replacement. "As I approach my fifth year as CEO, and after more than 35 years in Unilever, I believe now is the right time for the board to begin the formal search for my successor. Growth remains our top priority, and in the quarters ahead I will remain fully focused on disciplined execution of our strategy, and leveraging the full benefits of our new organisation," Jope said. The Dove soap maker added prominent shareholder Nelson Peltz to its board in May, rasing expectations of a shake-up at the company. Jope came under pressure earlier in 2022 after Unilever's failed takeover of GSK's consumer health business.

----------

GSK said Chief Financial Officer Iain Mackay will step down at the start of May 2023. GSK has named Julie Brown, Burberry Group PLC's chief operating & financial officer, to succeed Mackay. Brown has "extensive experience in the biopharma and medtech sectors", having had stints at AstraZeneca and Smith & Nephew. "Julie will join GSK in April 2023 and will work with Iain to transition responsibilities," GSK added.

----------

Retailer Frasers Group has made a mandatory takeover offer for AIM-listed online retailer MySale Group. Frasers said it now has just under a 49% interest in MySale, after receiving the backing from former MySale chair Carl Jackson. Jackson stepped down earlier in September. At 2 pence per share, the offer puts a GBP19 million valuation on all of MySale's equity. Frasers had owned just under 29% of MySale. "Frasers now intends to seek to acquire additional MySale Shares by means of market or other purchases and in accordance with the takeover code," Frasers explained. Earlier in September, MySale hit out at the 2p per share valuation for being too low. MySale operates e-commerce sites with a focus on the southern hemisphere, including nations such as Australia and New Zealand. Frasers owns retailers such as Sports Direct, House of Frasers and Evans Cycles.

----------

COMPANIES - FTSE 250

----------

Moneysupermarket.com Group named Niall McBride as its chief financial officer, subject to regulatory approval. McBride is currently the CFO of Ocado Group and Marks & Spencer joint-venture Ocado Retail. His start date is expected to be no later than April 3. He replaces Scilla Grimble who joins Deliveroo by no later than June 2023, the food delivery outfit said earlier this year.

----------

Babcock International left annual guidance unchanged, despite the aerospace and defence firm seeing "inflation and supply chain stress". Babcock said revenue and profit in the first five months of its financial year were in line with expectations. Babcock's financial year ends in March. "The market backdrop remains dynamic. Ongoing geopolitical uncertainty is leading to increased national defence requirements and potentially more opportunities, while macro factors such as inflation and supply chain stress increase delivery challenges," Babcock explained.

----------

OTHER COMPANIES

----------

Professional services firm RPS Group backed a GBP636 million takeover offer from Tetra Tech and withdrew its recommendation for a bid by Toronto-listed consultancy firm WSP Global. Nasdaq-listed consultancy and engineering services firm Tetra will pay 222 pence in cash for each RPS share, a 7.8% premium to the 206p offered by WSP. The WSP deal valued RPS at GBP591.1 million. "In light of the superior proposal per RPS share from Tetra Tech as compared to the WSP offer, the RPS directors, who have been so advised by Gleacher Shacklock and AEC Advisors as to the financial terms of the acquisition, consider the terms of the acquisition to be fair and reasonable," RPS said. WSP urged RPS shareholders to take no action.

----------

Car dealer Pendragon said it has received a takeover approach from vehicle showrooms operator Hedin Mobility Group. Hedin has offered 29p per Pendragon share, giving it an equity valuation of around GBP405 million. The bid is a 28% premium to Pendragon's 22.7p closing price on Friday. Pendragon has a market capitalisation of GBP317.1 million. "The board of Pendragon is currently considering the proposal together with its financial and legal advisers. Shareholders are urged to take no action at this time. There can be no certainty that any firm offer will be made," Pendragon added. Hedin has a 'put up or shut up' deadline of October 24. In March, Sky News reported that Pendragon had rejected a GBP400 million takeover approach from Hedin. In August, Pendragon said a "large international corporate" bidder for the car dealership chain decided against pursuing takeover talks, following due diligence.

----------

By Eric Cunha; ericcunha@alliancenews.com

Copyright 2022 Alliance News Limited. All Rights Reserved.

More News
17 Aug 2023 11:56

LONDON MARKET MIDDAY: Stocks down over US rate hike worries

(Alliance News) - Stock prices in Europe were lower at midday on Thursday, after the US Federal Reserve warned that a further interest rate hike may be on the cards.

Read more
17 Aug 2023 08:53

LONDON MARKET OPEN: Stocks fall further after hawkish US Fed minutes

(Alliance News) - Stock prices in London opened in the red on Thursday, amid renewed concerns about further US interest rate increases.

Read more
13 Aug 2023 14:06

Sunday newspaper round-up: White Hydrogen, Bank of England, AI

(Sharecast News) - America's Geological survey estimates that if even a small fraction of naturally occurring - and clean or so-called 'white' - hydrogen beneath the earth's surface were recovered, that would last for hundreds of years. Among the backers of the hydrogen industry is Bill Gates, who ploughed $90m into Koloma, a company hunting for natural hydrogen along the US's Midcontinental Rift System. White hydrogen has also been discovered in Europe, in France's Lorraine region. Nonetheless, the true potential of the stuff will hinge on the findings from those early projects, says Philip Ball, research fellow at Keele University. - Guardian

Read more
10 Aug 2023 15:46

UK dividends calendar - next 7 days

Friday 11 August 
Blackrock Latin American Investment Trust PLCdividend payment date
Caffyns PLCdividend payment date
CMC Markets PLCdividend payment date
Montanaro UK Smaller Cos Investment Trust PLCdividend payment date
Next 15 Group PLCdividend payment date
Ninety One PLC and Ltddividend payment date
Schroder European Real Estate Investment Trust PLCdividend payment date
Sportech PLCspecial dividend payment date
Telecom Plus PLCdividend payment date
Triad Group PLCdividend payment date
Wincanton PLCdividend payment date
Monday 14 August 
Mountview Estates PLCdividend payment date
Tuesday 15 August 
Tatton Asset Management PLCdividend payment date
Wednesday 16 August 
Murray International Trust PLCdividend payment date
Shoe Zone PLCdividend payment date
Thursday 17 August 
4imprint Group PLCex-dividend payment date
abrdn PLCex-dividend payment date
abrdn Property Income Trust Ltdex-dividend payment date
Anglo American PLCex-dividend payment date
Baillie Gifford UK Growth Trust PLCex-dividend payment date
Berkeley Group Holdings PLCex-dividend payment date
BlackRock Sustainable American Income Trust PLCex-dividend payment date
Bridgepoint Group PLCex-dividend payment date
Chemring Group PLCex-dividend payment date
ConvaTec Group PLCex-dividend payment date
Ecofin US Renewables Infrastructure Trust PLCex-dividend payment date
GSK PLCex-dividend payment date
Henderson Opportunities Trust PLCex-dividend payment date
Hiscox Ltdex-dividend payment date
Impact Healthcare REIT PLCex-dividend payment date
Imperial Brands PLCex-dividend payment date
Investec PLC and Ltdex-dividend payment date
iomart Group PLCex-dividend payment date
Keller Group PLCex-dividend payment date
Lancashire Holdings Ltdex-dividend payment date
London Stock Exchange Group PLCex-dividend payment date
Montanaro European Smaller Cos Trust PLCex-dividend payment date
Murray Income Trust PLCex-dividend payment date
NextEnergy Solar Fund Ltdex-dividend payment date
Octopus Renewables Infrastructure Trust PLCex-dividend payment date
Pershing Square Holdings Ltdex-dividend payment date
Rotork PLCex-dividend payment date
Sabre Insurance Group PLCex-dividend payment date
Schroders PLCex-dividend payment date
Sirius Real Estate Ltddividend payment date
Tritax EuroBox PLCex-dividend payment date
UK Commercial Property REIT Ltdex-dividend payment date
  
Copyright 2023 Alliance News Ltd. All Rights Reserved.

Read more
7 Aug 2023 08:12

PRESS: Inflexion among firms looking to buy Haleon's nicotine business

(Alliance News) - Sky News reported on Sunday that Inflexion Private Equity Partners is among suitors for Haleon PLC's Nicotinell anti-smoking aid.

Read more
3 Aug 2023 16:31

GSK Nigeria calls an end to its business, to return cash

ABUJA, Aug 3 (Reuters) - GlaxoSmithKline (GSK) Nigeria said on Thursday it plans to stop doing business after evaluating the options for moving to a third-party distribution model for its drugs and consumer healthcare goods.

Read more
2 Aug 2023 20:45

TOP NEWS: GSK sues Pfizer over patent infingements for RSV vaccine

(Alliance News) - GSK PLC on Wednesday sued Pfizer Inc over patent infringement, alleging Pfizer's respiratory syncytial virus vaccine steals key elements of GSK's version.

Read more
2 Aug 2023 15:14

GSK sues Pfizer in US for patent infringement over RSV vaccine

Aug 2 (Reuters) - British biopharmaceutical giant GSK sued Pfizer in a U.S. court on Wednesday, alleging that Pfizer's respiratory syncytial virus (RSV) vaccine Abrysvo violates GSK's patent rights in its rival RSV shot Arexvy.

Read more
2 Aug 2023 14:28

GSK sues Pfizer in US for patent infringement over RSV vaccine

Aug 2 (Reuters) - British biopharmaceutical giant GSK sued Pfizer in Delaware federal court on Wednesday, accusing Pfizer's respiratory syncytial virus (RSV) vaccine Abrysvo of violating GSK's patent rights in its rival RSV shot Arexvy.

Read more
2 Aug 2023 10:41

Sensodyne maker Haleon's shiny forecast signals price hikes unlikely to dent demand

Shares down 1% on slight decline in H1 adj operating margin

*

Read more
2 Aug 2023 08:23

TOP NEWS: Haleon boosts annual guidance after solid first half

(Alliance News) - Haleon PLC on Wednesday upped its annual organic revenue growth guidance following a solid revenue performance in the first half of 2023.

Read more
31 Jul 2023 19:42

IN BRIEF: GSK hails US FDA approval for cancer treatment, Jemperli

GSK PLC - London-based pharmaceutical company - Jemperli plus chemotherapy approved in the US by the Food & Drug Administration as the first new frontline treatment option in decades for primary advanced or recurrent endometrial cancer. Notes Jemperli is the only immuno-oncology treatment approved in the frontline setting for this patient population in combination with chemotherapy. Hesham Abdullah, senior vice president and global head of oncology development at GSK, says: "Today's approval underscore our belief in the potential for Jemperli to transform cancer treatment as a backbone immuno-oncology therapy."

Read more
31 Jul 2023 12:21

DIRECTOR DEALINGS: Qinetiq, Tesco and GSK executives sell shares

(Alliance News) - The following is a round-up of share dealings by London-listed company directors and managers announced late last week and not separately reported by Alliance News:

Read more
31 Jul 2023 09:16

LONDON BROKER RATINGS: Oddo BHF raises IAG to 'outperform'

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning:

Read more
26 Jul 2023 11:06

GSK raises 2023 outlook boosted by vaccine, HIV drug sales

Q2 sales and earnings beat estimates

*

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.